|
Drug Therapy, Other
Contributing journals to this collection:
JAMA & Archives Journals
Citations 11-20 of 2201 total displayed.
- Original Contributions
Intravenous Drug Administration During Out-of-Hospital Cardiac Arrest: A Randomized Trial
- Theresa M. Olasveengen; Kjetil Sunde; Cathrine Brunborg; Jon Thowsen; Petter A. Steen; Lars Wik
JAMA 2009; 302: 2222-2229.
[Abstract]
[Full text]
[PDF]
- Commentaries
Therapeutic Innovations, Diminishing Returns, and Control Rate Preservation
- David M. Kent; Thomas A. Trikalinos
JAMA 2009; 302: 2254-2256.
[Extract]
[Full text]
[PDF]
- Corrections
Error in Abstract in: Risk of Hyperkalemia in Nondiabetic Patients With Chronic Kidney Disease Receiving Antihypertensive Therapy
-
Arch Intern Med 2009; 169: 1968.
[Full text]
[PDF]
- Original Investigations
Costs and Consequences of Direct-to-Consumer Advertising for Clopidogrel in Medicaid
- Michael R. Law; Stephen B. Soumerai; Alyce S. Adams; Sumit R. Majumdar
Arch Intern Med 2009; 169: 1969-1974.
[Abstract]
[Full text]
[PDF]
- Original Investigations
Pooled Analysis of Rofecoxib Placebo-Controlled Clinical Trial Data: Lessons for Postmarket Pharmaceutical Safety Surveillance
- Joseph S. Ross; David Madigan; Kevin P. Hill; David S. Egilman; Yongfei Wang; Harlan M. Krumholz
Arch Intern Med 2009; 169: 1976-1985.
[Abstract]
[Full text]
[PDF]
[ eFigure and eTables ]
- Invited Commentary
Bringing the FDA's Information to Market
- Steven Woloshin; Lisa M. Schwartz
Arch Intern Med 2009; 169: 1985-1987.
[Extract]
[Full text]
[PDF]
- Original Investigations
Physician and Pharmacist Collaboration to Improve Blood Pressure Control
- Barry L. Carter; Gail Ardery; Jeffrey D. Dawson; Paul A. James; George R. Bergus; William R. Doucette; Elizabeth A. Chrischilles; Carrie L. Franciscus; Yinghui Xu
Arch Intern Med 2009; 169: 1996-2002.
[Abstract]
[Full text]
[PDF]
- Comments, Opinions, and Brief Case Reports
Direct-to-Consumer Offers for Free and Discounted Medications on the Internet: A Content Analysis of "e-Samples"
-
Arch Intern Med 2009; 169: 2024-2030.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
Optimal Anticoagulation Therapy in Patients With Valvular Heart Disease or Atrial Fibrillation
- Christopher J. McLeod; Bernard J. Gersh
Arch Intern Med 2009; 169: 2032-a-2033-a.
[Extract]
[Full text]
[PDF]
- Editor's Correspondence
The International Normalized Ratio Range of 2.0 to 3.0 Remains Appropriate for Atrial Fibrillation
- Daniel E. Singer; Margaret C. Fang; Alan S. Go
Arch Intern Med 2009; 169: 2032.
[Extract]
[Full text]
[PDF]
|
Advertisement


|
|
|